Key facts
- India's private healthcare sector has seen rapid expansion with thousands of new beds added quarterly.
- Private equity and M&A deals in Indian healthcare and pharma exceeded $30bn between 2022 and 2024.
- A government report indicates private hospital treatment can be five to 10 times more expensive than public facilities.
- The report cited "rampant commercialisation" leading to excessive billing and unnecessary diagnostics.
- Recommendations include capping hospital room tariffs and regulating essential treatments and diagnostics.
- The private healthcare sector argues that price caps would stifle investment and foreign investor interest.
India's private healthcare sector is experiencing a significant boom, with a proliferation of new hospitals, diagnostics centers, and clinics across the country, particularly in smaller towns. This expansion has been fueled by substantial investment, including nearly $1 billion raised by Manipal Health through an IPO and over $30 billion in mergers, acquisitions, and private equity transactions in the healthcare and pharma sectors between 2022 and 2024. Hospitals are rapidly adding beds and diagnostic chains are growing their footprint.
However, this growth has exacerbated an affordability crisis, according to a recent government panel report. Treatment in private hospitals is often five to 10 times more expensive than in public facilities, with the gap widening for serious illnesses. The report cited "unbridled growth" and "rampant commercialisation" leading to disparities in quality and cost, leaving patients vulnerable to arbitrary pricing, excessive billing, and unnecessary procedures, pushing vulnerable households into debt and distress.
The government panel has proposed measures such as capping hospital room tariffs, regulating essential treatments and diagnostics, and standardizing treatment guidelines. It also flagged concerns over foreign ownership exceeding 51% in hospital chains.
Industry representatives, like NATHEALTH, have pushed back against price caps, arguing that healthcare delivery is capital-intensive and that proposed caps would stifle investment and scare away foreign investors. They emphasize the need to reduce structural costs like taxes and land, rather than capping rates, and caution against comparing hospital tariffs to hotel tariffs due to compliance requirements.
Public health experts, however, argue for price regulation, citing the seller's market and "super profits" in the sector, with foreign private equity influencing pricing decisions. They also highlight the need to investigate increased emphasis on potentially unnecessary tests and diagnostics.
While some recommendations, like fairer taxation, could help reduce costs, experts stress the importance of strengthening public healthcare. India's current government health expenditure of 1.4% of GDP is below the 2.5% target and significantly lower than the WHO's recommended 5%. Experts believe increased public investment is necessary to reduce dependence on expensive private facilities, though an estimated $300 billion in additional healthcare investment is needed, much of which will likely come from private sources.